A role for activated macrophages in resistance to infection with Toxoplasma - PubMed (original) (raw)
A role for activated macrophages in resistance to infection with Toxoplasma
J S Remington et al. Infect Immun. 1972 Nov.
Abstract
Activated macrophages from mice which were chronically infected with Toxoplasma gondii or Besnoitia jellisoni, or which had received Freund complete adjuvant, had an enhanced capacity to to kill intracellular Toxoplasma. Enhanced killing by activated macrophages was demonstrated by decreased incorporation of isotopically labeled uridine by intracellular Toxoplasma and by inhibition of plaque formation. The latter resulted from lack of proliferation of the intracellular Toxoplasma which is normally followed by destruction of the host cell (macrophage) and secondary invasion and destruction of fibroblast monolayers.
Similar articles
- Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages.
Anderson SE Jr, Bautista SC, Remington JS. Anderson SE Jr, et al. Clin Exp Immunol. 1976 Dec;26(3):375-80. Clin Exp Immunol. 1976. PMID: 1009680 Free PMC article. - Effect of normal and activated human macrophages on Toxoplasma gondii.
Anderson SE Jr, Remington JS. Anderson SE Jr, et al. J Exp Med. 1974 May 1;139(5):1154-74. doi: 10.1084/jem.139.5.1154. J Exp Med. 1974. PMID: 4132992 Free PMC article. - Effect of alveolar macrophages on Toxoplasma gondii.
Ryning FW, Remington JS. Ryning FW, et al. Infect Immun. 1977 Dec;18(3):746-53. doi: 10.1128/iai.18.3.746-753.1977. Infect Immun. 1977. PMID: 591065 Free PMC article. - Influence of infection with Toxoplasma on macrophage function, and role of macrophages in resistance to Toxoplasma.
McLeod R, Remington JS. McLeod R, et al. Am J Trop Med Hyg. 1977 Nov;26(6 Pt 2):170-86. doi: 10.4269/ajtmh.1977.26.170. Am J Trop Med Hyg. 1977. PMID: 339761 Review. No abstract available. - Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii.
Gazzinelli RT, Amichay D, Sharton-Kersten T, Grunwald E, Farber JM, Sher A. Gazzinelli RT, et al. Curr Top Microbiol Immunol. 1996;219:127-39. doi: 10.1007/978-3-642-51014-4_12. Curr Top Microbiol Immunol. 1996. PMID: 8791695 Review. No abstract available.
Cited by
- The Impact of Helminth Coinfection on Innate and Adaptive Immune Resistance and Disease Tolerance during Toxoplasmosis.
Rovira-Diaz E, El-Naccache DW, Reyes J, Zhao Y, Nasuhidehnavi A, Chen F, Gause WC, Yap GS. Rovira-Diaz E, et al. J Immunol. 2022 Dec 1;209(11):2160-2171. doi: 10.4049/jimmunol.2200504. J Immunol. 2022. PMID: 36426972 Free PMC article. - Nanos gigantium humeris insidentes: old papers informing new research into Toxoplasma gondii.
Lodoen MB, Smith NC, Soldati-Favre D, Ferguson DJP, van Dooren GG. Lodoen MB, et al. Int J Parasitol. 2021 Dec;51(13-14):1193-1212. doi: 10.1016/j.ijpara.2021.10.004. Epub 2021 Nov 1. Int J Parasitol. 2021. PMID: 34736901 Free PMC article. Review. - Postinfectious Epigenetic Immune Modifications - A Double-Edged Sword.
DiNardo AR, Netea MG, Musher DM. DiNardo AR, et al. N Engl J Med. 2021 Jan 21;384(3):261-270. doi: 10.1056/NEJMra2028358. N Engl J Med. 2021. PMID: 33471978 Free PMC article. Review. No abstract available. - CD8 T Cells and Toxoplasma gondii: A New Paradigm.
Gigley JP, Bhadra R, Khan IA. Gigley JP, et al. J Parasitol Res. 2011;2011:243796. doi: 10.1155/2011/243796. Epub 2011 May 18. J Parasitol Res. 2011. PMID: 21687650 Free PMC article. - The CD8 T-cell road to immunotherapy of toxoplasmosis.
Bhadra R, Gigley JP, Khan IA. Bhadra R, et al. Immunotherapy. 2011 Jun;3(6):789-801. doi: 10.2217/imt.11.68. Immunotherapy. 2011. PMID: 21668315 Free PMC article. Review.
References
- Proc Soc Exp Biol Med. 1957 Oct;96(1):7-10 - PubMed
- Int Arch Allergy Appl Immunol. 1967;32(2):149-63 - PubMed
- Proc Soc Exp Biol Med. 1970 Feb;133(2):623-6 - PubMed
- Infect Immun. 1970 Jun;1(6):600-3 - PubMed
- J Immunol. 1972 Feb;108(2):425-31 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources